Horizon Therapeutics Public Limited Company is a biopharmaceutical company that develops and commercializes medicines for rare and rheumatic diseases. The company's portfolio includes treatments for gout, thyroid eye disease, and nephrology, as well as research programs in ophthalmology and gene therapy. Horizon Therapeutics is headquartered in Dublin, Ireland, and has offices in the United States and Europe. The company was founded in 2008 and has grown through a combination of internal development and strategic acquisitions. Horizon Therapeutics is committed to improving patient outcomes and has been recognized for its efforts in this area.